The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics

PL Toutain, JRE Del Castillo… - Research in veterinary …, 2002 - Elsevier
… Neutropenic mice are inoculated and treated with one of a wide range of dosage regimens
(varying dose and dosage interval) minimizing the interdependencies between the PD …

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

PN Patsalos - Pharmacology & therapeutics, 2000 - Elsevier
dosing regimens. With phenytoin, which exhibits saturable metabolism, a small increase in
dose … active metabolites that would require more complicated therapeutic dosing regimens. …

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

SC Chien, MC Rogge, LG Gisclon… - Antimicrobial agents …, 1997 - Am Soc Microbiol
… the start of the multiple dosing on day 4. Levofloxacin pharmacokinetics were linear and …
and intravenous dosing regimens, and the values of the pharmacokinetic parameters for the …

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics

ML Chen - Clinical pharmacokinetics, 2006 - Springer
… difference (or lack thereof) in pharmacokinetics/pharmacodynamics. The purpose of this …
of dosage regimen and dosage form on the data analysis and interpretation of pharmacokinetic

Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor–positive advanced breast cancer

P McCormack, F Sapunar - Clinical breast cancer, 2008 - Elsevier
… A pharmacokinetic model simulating plasma concentrations expected to be achieved with a
fulvestrant loading dose (LD) regimen … the pharmacokinetics of the fulvestrant LD regimen. …

Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients

C Li, JL Kuti, CH Nightingale… - The Journal of Clinical …, 2006 - Wiley Online Library
… a meropenem population pharmacokinetic model using patient data and use it to explore
alternative dosage regimens that could optimize the currently used dosing regimen to achieve …

[PDF][PDF] Design and optimization of dosage regimens: pharmacokinetic data

KE Thummel, DD Shen, N Isoherranen… - Goodman & Gilman's …, 2006 - ndl.ethernet.edu.et
… Under these circumstances, an estimate of the appropriate dosing regimen can be obtained
based on pharmacokinetic principles described in Chapter 1. Unless otherwise specified, …

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

J Muñoz, MR Ballester, RM Antonijoan… - PLoS neglected …, 2018 - journals.plos.org
… We report in this study safety and pharmacokinetic results of an alternative dosing regimen
for IVM. These results are of particular relevance for public health interventions based on …

Pharmacokinetic profile of a 2-month dose regimen of aripiprazole lauroxil: a phase I study and a population pharmacokinetic model

ML Hard, RJ Mills, BM Sadler, AY Wehr, PJ Weiden… - CNS drugs, 2017 - Springer
… the AL regimens to include a dose that could support a 2-month (every 8 weeks [q8wk]) dose
interval may offer additional medication regimen … Extensive pharmacokinetic sampling was …

Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis

J Lipman, J Scribante, AGS Gous, H Hon… - Antimicrobial agents …, 1998 - Am Soc Microbiol
… frequency of dosing in this dosing regimen cannot … pharmacokinetic parameters between
D2 and D7, particularly inV and C max (14); hence, we determined the pharmacokinetic profiles